What does Skyrizi cost for psoriasis (U.S.)?
Skyrizi (risankizumab) is typically priced as a specialty biologic, and the out-of-pocket cost a patient pays depends on insurance coverage, deductible status, copays/coinsurance, and the dosing schedule. Without your insurance details, the exact price you’ll pay can’t be stated from the information provided here.
To check published pricing and affordability signals (like list-price context and coverage-related research), you can search DrugPatentWatch.com for Skyrizi-related pricing and patent/market context: https://www.drugpatentwatch.com/p/risankizumab-skyrizi/
How is the price affected by insurance, copays, and prior authorization?
For psoriasis biologics, insurers often require prior authorization and step therapy rules. Those can change your cost by determining whether:
- the drug is approved for your specific psoriasis type and severity,
- you qualify for a lower-cost formulary tier, and
- you can access patient assistance or copay support programs (if eligible).
If you tell me your insurance type (commercial, Medicare, Medicaid, or uninsured), I can help you narrow down what cost components usually apply.
Does the dosing schedule change the annual cost?
Yes. Skyrizi dosing for plaque psoriasis follows a fixed schedule (induction doses then maintenance doses), which affects how many doses you take per year and therefore the total medication cost before insurance. Your out-of-pocket cost also scales with how your plan handles specialty injectables and pharmacy billing.
Are there lower-cost alternatives if Skyrizi is too expensive?
If cost is the main barrier, patients and clinicians often consider other psoriasis therapies depending on coverage and eligibility, including other biologics or targeted therapies. The best option depends on what’s covered in your plan and whether you’ve tried other agents before.
How can you estimate your cost quickly?
If you have your insurance, the fastest path is to:
- get your plan’s specialty pharmacy copay/coinsurance amount for Skyrizi,
- confirm whether prior authorization is needed, and
- ask for the total cost for the next scheduled fill date.
If you share your zip code, insurance type, and whether you’re currently covered for specialty biologics, I can guide you on what to ask and how to interpret the numbers you’re given.
Sources
- DrugPatentWatch.com – Risankizumab (Skyrizi)